Albemarle Corporation (NYSE:ALB) is a global leader in the production of specialty chemicals, with a focus on lithium, bromine, and refining catalysts. The company plays a significant role in the energy storage market, particularly with its lithium products, which are essential for electric vehicle batteries. Albemarle faces competition from other chemical companies like SQM and Livent.
On July 29, 2025, Piper Sandler downgraded Albemarle to a Neutral grade from Underweight, with the stock priced at $72.81. This downgrade, reported by Benzinga, was among the top five for the day. The downgrade comes as Albemarle prepares to release its second-quarter earnings, with anticipated revenue decline of 13.1% compared to the previous year. Despite challenges from declining lithium prices, Albemarle's cost-saving measures are expected to support profit margins.
The Energy Storage unit is projected to see a significant sales drop of 28.4%, while the Specialties segment may experience an increase of 11.3%. Over the past year, Albemarle's shares have decreased by 19.2%, reflecting the company's struggles. Historically, Albemarle has missed the Zacks Consensus Estimate for earnings in three of the last four quarters, with an average negative earnings surprise of 136%.
However, the most recent quarter showed a positive earnings surprise of 71%. Currently, ALB is priced at $72.50, having decreased by 3.04% today, with a trading volume of 1,683,290 shares. Albemarle's stock has seen a high of $113.91 and a low of $49.43 over the past year. The company's market capitalization stands at approximately $8.53 billion. As Albemarle navigates these financial challenges, investors will be closely watching the upcoming earnings release for further insights into the company's performance.
